Myth 3: If it helped one symptom, it can replace treatment The truth: Recovery is complex
The risks at a physician-supervised clinic are substantially lower than at unsupervised IV bars
All trials employed randomized, double-blind, placebo-controlled designs, representing the gold standard for clinical research
Lightheadedness is typically most pronounced during the initial weeks of tirzepatide therapy or following dose escalation, often improving as the body adjusts over several days to weeks
These studies attempt to replicate prior findings, identify adverse effects and determine the efficacy during prolonged use
Notably, accumulating evidence has shown that structured chronic PE training or high cardiorespiratory fitness (CRF) decreases the risk of OS-related pathologies (Farrell et al., 2012